Cargando…
A nutraceutical strategy for downregulating TGFβ signalling: prospects for prevention of fibrotic disorders, including post-COVID-19 pulmonary fibrosis
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061562/ https://www.ncbi.nlm.nih.gov/pubmed/33879509 http://dx.doi.org/10.1136/openhrt-2021-001663 |
| _version_ | 1783681590817193984 |
|---|---|
| author | DiNicolantonio, James J McCarty, Mark F Barroso-Aranda, Jorge Assanga, Simon Lujan, Lidianys Maria Lewis O'Keefe, James H |
| author_facet | DiNicolantonio, James J McCarty, Mark F Barroso-Aranda, Jorge Assanga, Simon Lujan, Lidianys Maria Lewis O'Keefe, James H |
| author_sort | DiNicolantonio, James J |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8061562 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80615622021-04-22 A nutraceutical strategy for downregulating TGFβ signalling: prospects for prevention of fibrotic disorders, including post-COVID-19 pulmonary fibrosis DiNicolantonio, James J McCarty, Mark F Barroso-Aranda, Jorge Assanga, Simon Lujan, Lidianys Maria Lewis O'Keefe, James H Open Heart Editorial BMJ Publishing Group 2021-04-20 /pmc/articles/PMC8061562/ /pubmed/33879509 http://dx.doi.org/10.1136/openhrt-2021-001663 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Editorial DiNicolantonio, James J McCarty, Mark F Barroso-Aranda, Jorge Assanga, Simon Lujan, Lidianys Maria Lewis O'Keefe, James H A nutraceutical strategy for downregulating TGFβ signalling: prospects for prevention of fibrotic disorders, including post-COVID-19 pulmonary fibrosis |
| title | A nutraceutical strategy for downregulating TGFβ signalling: prospects for prevention of fibrotic disorders, including post-COVID-19 pulmonary fibrosis |
| title_full | A nutraceutical strategy for downregulating TGFβ signalling: prospects for prevention of fibrotic disorders, including post-COVID-19 pulmonary fibrosis |
| title_fullStr | A nutraceutical strategy for downregulating TGFβ signalling: prospects for prevention of fibrotic disorders, including post-COVID-19 pulmonary fibrosis |
| title_full_unstemmed | A nutraceutical strategy for downregulating TGFβ signalling: prospects for prevention of fibrotic disorders, including post-COVID-19 pulmonary fibrosis |
| title_short | A nutraceutical strategy for downregulating TGFβ signalling: prospects for prevention of fibrotic disorders, including post-COVID-19 pulmonary fibrosis |
| title_sort | nutraceutical strategy for downregulating tgfβ signalling: prospects for prevention of fibrotic disorders, including post-covid-19 pulmonary fibrosis |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061562/ https://www.ncbi.nlm.nih.gov/pubmed/33879509 http://dx.doi.org/10.1136/openhrt-2021-001663 |
| work_keys_str_mv | AT dinicolantoniojamesj anutraceuticalstrategyfordownregulatingtgfbsignallingprospectsforpreventionoffibroticdisordersincludingpostcovid19pulmonaryfibrosis AT mccartymarkf anutraceuticalstrategyfordownregulatingtgfbsignallingprospectsforpreventionoffibroticdisordersincludingpostcovid19pulmonaryfibrosis AT barrosoarandajorge anutraceuticalstrategyfordownregulatingtgfbsignallingprospectsforpreventionoffibroticdisordersincludingpostcovid19pulmonaryfibrosis AT assangasimon anutraceuticalstrategyfordownregulatingtgfbsignallingprospectsforpreventionoffibroticdisordersincludingpostcovid19pulmonaryfibrosis AT lujanlidianysmarialewis anutraceuticalstrategyfordownregulatingtgfbsignallingprospectsforpreventionoffibroticdisordersincludingpostcovid19pulmonaryfibrosis AT okeefejamesh anutraceuticalstrategyfordownregulatingtgfbsignallingprospectsforpreventionoffibroticdisordersincludingpostcovid19pulmonaryfibrosis AT dinicolantoniojamesj nutraceuticalstrategyfordownregulatingtgfbsignallingprospectsforpreventionoffibroticdisordersincludingpostcovid19pulmonaryfibrosis AT mccartymarkf nutraceuticalstrategyfordownregulatingtgfbsignallingprospectsforpreventionoffibroticdisordersincludingpostcovid19pulmonaryfibrosis AT barrosoarandajorge nutraceuticalstrategyfordownregulatingtgfbsignallingprospectsforpreventionoffibroticdisordersincludingpostcovid19pulmonaryfibrosis AT assangasimon nutraceuticalstrategyfordownregulatingtgfbsignallingprospectsforpreventionoffibroticdisordersincludingpostcovid19pulmonaryfibrosis AT lujanlidianysmarialewis nutraceuticalstrategyfordownregulatingtgfbsignallingprospectsforpreventionoffibroticdisordersincludingpostcovid19pulmonaryfibrosis AT okeefejamesh nutraceuticalstrategyfordownregulatingtgfbsignallingprospectsforpreventionoffibroticdisordersincludingpostcovid19pulmonaryfibrosis |